Steatohepatitis and cirrhosis: First manifestation 23 years after jejunoileal bypass surgery;Steatohepatitis und leberzirrhose: Erstmanifestation 23 jahre nach jejunoilealem bypass

Wiener Klinische Wochenschrift

Volumn 119, Issue 23-24, 2007, Pages 733-738

  Piringer, Peter ^a   Buder, Robert ^a   Firlinger, Fritz ^a   Kapral, Christine ^a   Luft, Christian ^a   Sega, Wolfgang ^b   Wewalka, Friedrich ^a   Lenz, Kurt ^a,c  

^a KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Austria)

^b Krankenhaus der Barmherzigen Schwestern Wien Betriebsgesellschaft   (Austria)

^c Medizinische Abteilung   (Austria)

Author keywords

Cirrhosis; Jejunoileal bypass; Steatohepatitis

Indexed keywords

CHOLESTEROL;

ADULT; ARTICLE; CASE REPORT; DISEASE SEVERITY; FATTY LIVER; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; INTERNATIONAL NORMALIZED RATIO; JEJUNOILEAL BYPASS; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION;

FATTY LIVER; FEMALE; HEPATITIS; HUMANS; JEJUNOILEAL BYPASS; LIVER CIRRHOSIS; MIDDLE AGED;

EID: 37749013673     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-007-0850-z     Document Type: Article

References (37)

1. Deitel M (2003) Overweight and obesity worldwide now estimated to involve 1.7 billion people. Obes Surg 13: 329-330
2. Demaria EJ (2007) Bariatric surgery for morbid obesity. N Engl J Med 356: 2176-2183
3. Engl J, Hanusch-Enserer U, Prager R, Patsch JR, Ebenbichler C (2005) The metabolic syndrome: effects of a pronounced weight loss induced by bariatric surgery. Wien Klin Wochenschr 117: 243-254
4. Deitel M, Shikora SA (2002) The development of the surgical treatment of morbid obesity. J Am Coll Nutr 21: 365-371
5. Elder KA, Wolfe BM (2007) Bariatric surgery: a review of procedures and outcomes. Gastroenterology 132: 2253- 2271
6. DeWind LT, Payne JH (1976) Intestinal bypass surgery for morbid obesity. Long-term results. JAMA 236: 2298- 2301
7. Scott HW Jr, Law DH (1969) Clinical appraisal of jejunoileal shunt in patients with morbid obesity. Am J Surg 117: 246-253
8. Maxwell JD, McGouran RC (1982) Jejuno-ileal bypass: clinical and experimental aspects. Scand J Gastroenterol [Suppl] 74: 129-147
9. O'Leary JP (1983) Hepatic complications of jejunoileal bypass. Semin Liver Dis 3: 203-215
10. Requarth JA, Burchard KW, Colacchio TA, Stukel TA, Mott LA, Greenberg ER, Weismann RE (1995) Long-term morbidity following jejunoileal bypass. The continuing potential need for surgical reversal. Arch Surg 130: 318-325
11. Hocking MP, Davis GL, Franzini DA, Woodward ER (1998) Long-term consequences after jejunoileal bypass for morbid obesity. Dig Dis Sci 43: 2493-2499
12. O'Leary JP (1992) Gastrointestinal malabsorptive procedures. Am J Clin Nutr 55: 567S-570S
13. Organ CH Jr, Cegielski MM, Grabner BJ, Keig HE, Saporta JA (1980) Jejunoileal bypass. Long-term results. Ann Surg 192: 38-43
14. Kaminski DL, Herrmann VM, Martin S (1985) Late effects of jejunoileal bypass operations on hepatic inflammation, fibrosis and lipid content. Hepatogastroenterology 32: 159-162
15. Boon AP, Thompson H, Baddeley RM (1988) Use of histological examination to assess ultrastructure of liver in patients with long standing jejuno-ileal bypass for morbid obesity. J Clin Pathol 41: 1281-1287
16. Plauth M, Cabre E, Riggio O, Assis-Camilo M, Pirlich M, Kondrup J, Ferenci P, Holm E, Vom DS, Muller MJ, Nolte W (2006) ESPEN Guidelines on Enteral Nutrition: Liver disease. Clin Nutr 25: 285-294
17. Trauner M (2007) A little orphan to fat: The orphan recepeptor smal hereodimer partner as a key player in the regulation of hepativ lipid metabolism. Hepatology 46: 1-5
18. Charlton M, Kasparova P, Weston S, Lindor K, Maor-Kendler Y, Wiesner RH, Rosen CB, Batts KP (2003) Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease. Liver Transplantation 7: 608-614
19. Clark JM, Brancati FL (2004) Negative trials in nonalcoholic steatohepatitis: Why the happen and what they teach us. Hepatology 39: 602-603
20. Jaskiewicz K, Raczynska S, Rzepko R, Sledzinski Z (2006) Nonalcoholic fatty liver disease treated by gastroplasty. Dig Dis Sci 51: 21-26
21. Mattar SG, Velcu LM, Rabinovitz M, Demetri AJ, Krasinskas AM, Barinas-Mitchell E, et al (2005) Surgically induced weight loss significantly imporves non-alcoholic fatty liver disease and the metabolic syndrome. Ann Surch 242: 610-620
22. Furuya CK, de Oliveira CPM, de Mello ES, Faintuch J, Raskovski A, Matsuda M, et al (2007) Effects of bariatric surgery on non-alcoholic fatty liver disease: Preliminary findings after 2 years. J Gastroenterol Hepatol 22: 510- 514
23. Klein S, Mittendorfer B, Eagon JC, Patterson B, Grant L, Feirt N, Seki E, Brenner D, Korenblat K, McCrea J (2006) Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease. Gastroenterology 130: 1564-1572
24. Lichtman SN, Keku J, Schwab JH, Sartor RB (1991) Evidence for peptidoglycan absorption in rats with experimental small bowel bacterial overgrowth. Infect Immun 59: 555-562
25. Brun P, Castagliuolo I, Leo VD, Buda A, Pinzani M, Palu G, Martines D (2007) Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 292: G518-G525
26. Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Grose RH, Cummins AG (2001) The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 48: 206-211
27. Drenick EJ, Fisler J, Johnson D (1982) Hepatic steatosis after intestinal bypass - prevention and reversal by metronidazole, irrespective of protein-calorie malnutrition. Gastroenterology 82: 535-548
28. Lichtman SN, Keku J, Schwab JH, Sartor RB (1991) Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline. Gastroenterology 100: 513-519
29. Dean P, Joshi S, Kaminski DL (1990) Long-term outcome of reversal of small intestinal bypass operations. Am J Surg 159: 118-123
30. Buchwald H, Williams SE (2004) Bariatric surgery worldwide 2003. Obes Surg 14: 1157-1164
31. Haines NW, Baker AL, Boyer JL, Glagov S, Schneir H, Jaspan J, Ferguson DJ (1981) Prognostic indicators of hepatic injury following jejunoileal bypass performed for refractory obesity: a prospective study. Hepatology 1: 161-167
32. Markowitz JS, Seu P, Goss JA, Yersiz H, Markmann JF, Farmer DG, Ghobrial RM, Goldstein LI, Martin P, Stribling R, Busuttil RW (1998) Liver transplantation for decompensated cirrhosis after jejunoileal bypass: a strategy for management. Transplantation 65: 570-572
33. Laurin J, Lindor KD, Crippin JS, Gossard A, Gores GJ, Ludwig J, Rakela J, McGill DB (1996) Ursodeoxycholic acid or clofibrate in the treatment of non-alcoholic-induced steatohepatitis: a pilot study. Hepatology 23: 1464-1467
34. Fan JG, Zhong L, Tia LY, Xu ZJ, Li MS, Wang GL (2005) Effects of ursodeoxycholic acid and/or low-calorie diet on steatohepatitis in rats with obesity and hyperlipidemia. World J Gastroenterol 11: 2346-2350
35. Lindor KD, Kowdley KV, Heathcote EJ, Harrison ME, Jorgensen R, Angulo P, Lymp JF, Burgart L, Colin P (2004) Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial. Hepatology 39: 770-778
36. Kapral C, Wewalka F, Praxmarer V, Lenz K, Hofmann AF (2004) Conjugated bile acid replacement therapy in short bowel syndrome patients with a residual colon. Z Gastroenterol 42: 583-589
37. Lorenzo-Zuniga V, Bartoli R, Planas R, Hofmann AF, Vinado B, Hagey LR, Hernandez JM, Mane J, Alvarez MA, Ausina V, Gassull MA (2003) Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats. Hepatology 37: 551-557